- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/33 - Composés hétérocycliques
Détention brevets de la classe A61K 31/33
Brevets de cette classe: 3140
Historique des publications depuis 10 ans
61
|
56
|
58
|
41
|
52
|
40
|
74
|
485
|
556
|
451
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Merck Sharp & Dohme LLC | 3756 |
48 |
The Regents of the University of California | 20137 |
44 |
University of Florida Research Foundation, Inc. | 4052 |
34 |
Purdue Research Foundation | 3676 |
29 |
The Board of Trustees of the Leland Stanford Junior University | 6487 |
26 |
Board of Regents, The University of Texas System | 5884 |
22 |
Praxis Precision Medicines, Inc. | 179 |
22 |
The Johns Hopkins University | 5723 |
21 |
The General Hospital Corporation | 4781 |
20 |
The Trustees of Columbia University in the City of New York | 3592 |
20 |
Amarin Pharmaceuticals Ireland Limited | 271 |
20 |
Dana-Farber Cancer Institute, Inc. | 2600 |
20 |
Emory University | 1641 |
17 |
The Scripps Research Institute | 1347 |
16 |
Yale University | 2422 |
16 |
The Trustees of the University of Pennsylvania | 4354 |
15 |
Kymera Therapeutics, Inc. | 233 |
15 |
Caamtech, Inc. | 148 |
15 |
Bristol-myers Squibb Company | 4850 |
14 |
The Regents of the University of Michigan | 4753 |
14 |
Autres propriétaires | 2692 |